PROPHYLAXIS AGAINST SEPTICEMIA IN ACUTE LEUKEMIA: THE USE OF ORAL FRAMYCETIN

Abstract
Septicaemia during remission‐induction therapy for acute leukaemia has been a major limiting factor in treatment of the disease and highly expensive regimes have been advocated to reduce this complic...